RxDoctor Payments Data

Ashley Walton, APRN

Nurse Practitioner · St Petersburg, FLNPI 1518443803

Payments from drug & device makers

$5,567in general payments, 2019–2025

Across 288 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$959
  • Johnson & Johnson$803
  • UCB, Inc.$667
  • AbbVie$460
  • Mallinckrodt Hospital Products Inc.$398
  • E.r. Squibb & Sons, L.L.C.$312
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$5,52299%
  • Education$451%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,567 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Medicare billing

Part B allowed, 2024
$6,745
Medicare patients
50
Services billed
94

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept32$233,206
Orencia ClickjectAbatacept32$180,622
RinvoqUpadacitinib18$124,267
Humira(Cf) PenAdalimumab13$101,421
Actemra ActpenTocilizumab13$30,707
Hydroxychloroquine Sulfate144$3,637
MethotrexateMethotrexate Sodium119$2,661
Celecoxib38$1,944
Leflunomide24$1,209
Prednisone216$1,095
Sulfasalazine57$667
Allopurinol22$273
Methylprednisolone32$272
Folic Acid25$234
Methocarbamol15$223

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq$460$124,26718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in St Petersburg

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →